Amprion Newsroom
Recent media coverage and announcements.
News Article
Today's Clinical Lab
New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments
November 14, 2025
Read MoreNews Article
Neurology Live
Revolutionizing Dementia Research With Synuclein Biomarker Tests
August 13, 2023
Read MoreNews Article
Washington Post
Parkinson's is often misdiagnosed. New tests may change that.
October 10, 2024
Read MoreNews Article
Precision Medicine Online
NIH Researchers to Use Amprion CSF Test in Dementia Biomarker Validation Study
August 24, 2023
Read MoreNews Article
Fierce Biotech
New test detects Parkinson's biomarker before movement symptoms start
4/18/2023
Read MoreNews Article
Everyday Health
Lab Test May Detect Parkinson's Disease Even Before Symptoms Appear
4/17/2023
Read MoreNews Article
Parkinson's News Today
FDA letter supports use of new alpha-synuclein assay in trials
9/9/2024
Read MoreNews Article
360Dx
FDA Letter of Support Could Boost Use of Parkinson's Biomarker in Clinical Trials
9/19/2024
Read MoreNews Article
Clinical Lab Products
FDA Issues Letter of Support for Alpha-Synuclein Seed Amplification Assay
9/5/2024
Read MoreNews Article
Endpoints
Exclusive: A small San Diego biotech wants to change how Parkinson's disease is diagnosed
10/8/2024
Read MoreNews Article
HCP Live
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
12/8/2023
Read MoreNews Article
PharmaVoice
As new Alzheimer's biomarkers come into play here's where the money is going
10/17/2024
Read MoreNews Article
PharmiWeb
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
7/29/2024
Read MoreNews Article
360Dx
Amprion's Parkinson's Disease Dx Shows Strong Performance in Study
4/26/2023
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
